The McGill Regenerative Medicine Network (MRM Network) is committed to creating a research network that tackles research priorities leading to the advancement of scientific knowledge in the field of regenerative medicine at McGill University and beyond. The MRM also facilitates the translation of new discoveries into clinical practice, train a new generation of regenerative medicine investigators and aims to address societal and ethical issues associated with the use of these technologies. The MRM Network strives to promote strong transdisciplinary connections between fundamental and clinical research at McGill University.
By its nature, the broad field of Regenerative Medicine research is interdisciplinary, spanning fundamental to translational research from molecular biology and stem cells to tissue engineering and beyond. These biomedical programs use original processes of replacing, engineering or regenerating human cells, tissues or organs in order to restore or establish normal function. To achieve our Mission and to meet our core strategies and commitments, we set several overarching priorities to steer developments of regenerative medicine and formalize its community of basic and clinical researchers.
We seek to assemble, recruit and develop the best academic staff and interdisciplinary regenerative medicine researchers in the McGill scientific community. Together we will train the next competitive and innovative generation of MRM researchers. We aim to understand the fundamental mechanism of relevant regenerative medicine biology and their clinical potential.
For this, we will pursue the development of innovative technologies to manipulate and apply stem cells to regenerative medicine. From today and throughout the next five years we will promote MRM scientists and their research locally, nationally and internationally. In doing so, we expect to increase our visibility and partnering; and strengthen our financial support and resources. Our goal is to apply current knowledge and technologies for launching clinical trials, private sector activities and multidisciplinary collaborations across faculties, departments, research institutes and hospitals. We also give a priority to conducting activities that simultaneously expand the legal and ethical bases for guiding and communicating MRM research and its societal contributions.
Following a broad survey of McGill researchers and key stakeholders in regenerative medicine, we identified five major consensus commitments to move McGill Regenerative Medicine forward.
- Commitment 1: To expand our footprint from McGill to the world
Establishing and promoting the MRM network from seminars to conferences, media releases, and international scientific outreach.
- Commitment 2: To understand and to translate regenerative medicine biology
Encouraging and financing basic infrastructure, and fundamental research programs of MRM across McGill and affiliated institutions.
- Commitment 3: To develop and implement MRM clinical pipelines
Supporting diverse clinical pipelines and sustaining translational research from Phase 1 to Phase 3 trials at our hospitals and research institutes.
- Commitment 4: To foster the next generation of transdisciplinary regenerative medicine HQP
Building and implementing a graduate training program to expand mentorships and interest in regenerative medicine.
- Commitment 5: To develop and sustain impactful actions in clinical applications, ethical, legal and social implications of regenerative medicine research
Assisting McGill researchers to change and update ethical guidelines, as well as regenerative medicine knowledge and applications for the public.